Opsens (TSE:OPS) Stock Price Up 11.6% Following Analyst Upgrade

Shares of Opsens Inc. (TSE:OPS) rose 11.6% during trading on Wednesday after Raymond James raised their price target on the stock to C$6.00. Raymond James currently has an outperform rating on the stock. Opsens traded as high as C$3.00 and last traded at C$2.89. Approximately 172,390 shares changed hands during mid-day trading, an increase of 3% from the average daily volume of 167,173 shares. The stock had previously closed at C$2.59.

OPS has been the topic of several other reports. M Partners set a C$2.25 target price on shares of Opsens in a research report on Wednesday, July 14th. Royal Bank of Canada reiterated a “buy” rating and set a C$3.50 price target on shares of Opsens in a report on Tuesday.

The company has a debt-to-equity ratio of 29.99, a quick ratio of 5.85 and a current ratio of 6.75. The firm has a market capitalization of C$312.97 million and a P/E ratio of 370.00. The stock’s 50 day simple moving average is C$2.54 and its 200 day simple moving average is C$2.17.

Opsens (TSE:OPS) last announced its quarterly earnings results on Tuesday, July 13th. The company reported C($0.01) earnings per share for the quarter. The firm had revenue of C$9.23 million for the quarter, compared to analysts’ expectations of C$9.20 million. On average, analysts anticipate that Opsens Inc. will post 0.02 earnings per share for the current year.

Opsens Company Profile (TSE:OPS)

Opsens Inc develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology.

Featured Story: Trade War

Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.